Zhengye Biotech says no material non-public information behind unusual share trading activity

Zhengye Biotechnology Holding issued a statement addressing unusual price and volume moves in its Nasdaq-listed Class A ordinary shares.

The company said it is not aware of any material non-public information or undisclosed developments that could explain the trading activity, and added that operations are continuing normally.

Zhengye said it has remained in contact with Nasdaq about the volume spike and will cooperate with Nasdaq and other regulators as appropriate.

The company urged investors to use caution amid the volatility and said they should rely on SEC filings.